Research interests include Immune cells in cancer, Cancer Immunotherapy and Biomarkers, Ferroptosis and cancer prognosis, and Pancreatic and Hepatic Oncology Research.
Efficacy and safety of PD-1 inhibitors combined with chemotherapy as first-line therapy for advanced esophageal cancer: A systematic review and network meta-analysis
International Immunopharmacology2022cited by 47position: firstdoi